These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11732998)

  • 1. Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Design of a potent endozepine antagonist.
    Leprince J; Oulyadi H; Vaudry D; Masmoudi O; Gandolfo P; Patte C; Costentin J; Fauchère JL; Davoust D; Vaudry H; Tonon MC
    Eur J Biochem; 2001 Dec; 268(23):6045-57. PubMed ID: 11732998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of a series of analogues of the octadecaneuropeptide ODN on calcium mobilization in rat astrocytes.
    Leprince J; Gandolfo P; Thoumas JL; Patte C; Fauchère JL; Vaudry H; Tonon MC
    J Med Chem; 1998 Nov; 41(23):4433-8. PubMed ID: 9804683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of a series of analogs of the endozepine octadecaneuropeptide (ODN(11)(-)(18)) on neurosteroid biosynthesis by hypothalamic explants.
    Rego JL; Leprince J; Luu-The V; Pelletier G; Tonon MC; Vaudry H
    J Med Chem; 2007 Jun; 50(13):3070-6. PubMed ID: 17550241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: evidence for an endozepinergic tone regulating food intake.
    do Rego JC; Orta MH; Leprince J; Tonon MC; Vaudry H; Costentin J
    Neuropsychopharmacology; 2007 Jul; 32(7):1641-8. PubMed ID: 17151595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the diazepam-binding inhibitor-derived peptide, octadecaneuropeptide, on food intake in goldfish.
    Matsuda K; Wada K; Miura T; Maruyama K; Shimakura SI; Uchiyama M; Leprince J; Tonon MC; Vaudry H
    Neuroscience; 2007 Dec; 150(2):425-32. PubMed ID: 17936516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endozepine ODN stimulates polyphosphoinositide metabolism in rat astrocytes.
    Patte C; Vaudry H; Desrues L; Gandolfo P; Strijdveen I; Lamacz M; Tonon MC
    FEBS Lett; 1995 Apr; 362(2):106-10. PubMed ID: 7720854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The octadecaneuropeptide ODN protects astrocytes against hydrogen peroxide-induced apoptosis via a PKA/MAPK-dependent mechanism.
    Hamdi Y; Kaddour H; Vaudry D; Bahdoudi S; Douiri S; Leprince J; Castel H; Vaudry H; Tonon MC; Amri M; Masmoudi-Kouki O
    PLoS One; 2012; 7(8):e42498. PubMed ID: 22927932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates endozepine release from cultured rat astrocytes via a PKA-dependent mechanism.
    Masmoudi O; Gandolfo P; Leprince J; Vaudry D; Fournier A; Patte-Mensah C; Vaudry H; Tonon MC
    FASEB J; 2003 Jan; 17(1):17-27. PubMed ID: 12522108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stimulatory effect of the octadecaneuropeptide (ODN) on cytosolic Ca2+ in rat astrocytes is not mediated through classical benzodiazepine receptors.
    Gandolfo P; Patte C; Leprince J; Thoumas JL; Vaudry H; Tonon MC
    Eur J Pharmacol; 1997 Mar; 322(2-3):275-81. PubMed ID: 9098698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endozepine ODN stimulates [3H]thymidine incorporation in cultured rat astrocytes.
    Gandolfo P; Patte C; Thoumas JL; Leprince J; Vaudry H; Tonon MC
    Neuropharmacology; 1999 May; 38(5):725-32. PubMed ID: 10340310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endogenous benzodiazepine receptor ligand ODN increases cytosolic calcium in cultured rat astrocytes.
    Lamacz M; Tonon MC; Smih-Rouet F; Patte C; Gasque P; Fontaine M; Vaudry H
    Brain Res Mol Brain Res; 1996 Apr; 37(1-2):290-6. PubMed ID: 8738163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection, characterization and biological activities of [bisphospho-thr3,9]ODN, an endogenous molecular form of ODN released by astrocytes.
    Gach K; Belkacemi O; Lefranc B; Perlikowski P; Masson J; Walet-Balieu ML; Do-Rego JC; Galas L; Schapman D; Lamtahri R; Tonon MC; Vaudry D; Chuquet J; Leprince J
    Neuroscience; 2015 Apr; 290():472-84. PubMed ID: 25639232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant and Anti-Apoptotic Activity of Octadecaneuropeptide Against 6-OHDA Toxicity in Cultured Rat Astrocytes.
    Kaddour H; Hamdi Y; Amri F; Bahdoudi S; Bouannee I; Leprince J; Zekri S; Vaudry H; Tonon MC; Vaudry D; Amri M; Mezghani S; Masmoudi-Kouki O
    J Mol Neurosci; 2019 Sep; 69(1):1-16. PubMed ID: 30343367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The octadecaneuropeptide exerts an anxiogenic-like action in goldfish.
    Matsuda K; Wada K; Azuma M; Leprince J; Tonon MC; Sakashita A; Maruyama K; Uchiyama M; Vaudry H
    Neuroscience; 2011 May; 181():100-8. PubMed ID: 21382452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo action of a new octadecaneuropeptide antagonist on neuropeptide Y and corticotropin-releasing hormone mRNA levels in rat.
    Compère V; Li S; Leprince J; Tonon MC; Vaudry H; Pelletier G
    Brain Res Mol Brain Res; 2005 Nov; 141(2):156-60. PubMed ID: 16154662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The octadecaneuropeptide ODN prevents 6-hydroxydopamine-induced apoptosis of cerebellar granule neurons through a PKC-MAPK-dependent pathway.
    Kaddour H; Hamdi Y; Vaudry D; Basille M; Desrues L; Leprince J; Castel H; Vaudry H; Tonon MC; Amri M; Masmoudi-Kouki O
    J Neurochem; 2013 May; 125(4):620-33. PubMed ID: 23286644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octadecaneuropeptide ODN prevents hydrogen peroxide-induced oxidative damage of biomolecules in cultured rat astrocytes.
    Hamdi Y; Kaddour H; Vaudry D; Leprince J; Zarrouk A; Hammami M; Vaudry H; Tonon MC; Amri M; Masmoudi-Kouki O
    Peptides; 2015 Sep; 71():56-65. PubMed ID: 26143507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catabolism of the octadecaneuropeptide ODN by prolyl endopeptidase: identification of an unusual cleavage site.
    Leprince J; Cosquer D; Bellemère G; Chatenet D; Tollemer H; Jégou S; Tonon MC; Vaudry H
    Peptides; 2006 Jun; 27(6):1561-9. PubMed ID: 16406204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo action of a new octadecaneuropeptide (ODN) antagonist on gonadotropin-releasing hormone gene expression in the male rat brain.
    Compère V; Li S; Leprince J; Tonon MC; Vaudry H; Pelletier G
    Neuroscience; 2004; 125(2):411-5. PubMed ID: 15062983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection with the Endozepine Octadecaneuropeptide, ODN.
    Masmoudi-Kouki O; Hamdi Y; Ghouili I; Bahdoudi S; Kaddour H; Leprince J; Castel H; Vaudry H; Amri M; Vaudry D; Tonon MC
    Curr Pharm Des; 2018; 24(33):3918-3925. PubMed ID: 30417780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.